Entry to the U.S. requires more proof of vaccination than should be necessary, while unvaccinated people are free to fly anywhere within the country.
Max NisenEquity Associate Analyst
Max Nisen is a healthcare analyst at Bloomberg Intelligence. He previously wrote for Bloomberg Opinion, Quartz and Business Insider.
In a shift toward much-needed flexibility, drug regulators will enable all Americans seeking greater protection against Covid-19 to easily get it.
The former military officer and statesman needed as many people around him as possible to be vaccinated to diminish his chances of encountering the virus.
The antivirals may be approved before year’s end. But healthy people under 65 may not get them.
It should also be relatively easy to scale up manufacturing and get pills out to the people who need them worldwide.
One attempt to repair a faulty eye gene had disappointing results, but the technology can be expected to one day treat all sorts of genetic diseases.
Highly convenient oral drugs could be a pandemic game changer. With enough investment, the U.S. could make a whole lot of them for the world.
U.S. experts had a difficult series of decisions to make about boosters based on limited data. But it’s hard to say their final advice is clear, evidence-based or in the best interests of public health.
From the need for boosters to kids and Covid and the risk of new variants, here’s what you need to know.
Setting a timeline before experts weighed in put improper pressure on scientific agencies, raised expectations and now risks creating confusion when the focus should be on first shots.
The airline is the first major corporation to say it will slap a big health-insurance surcharge on workers who haven’t had their Covid-19 shots. Is this a good idea?
Illumina closes its $8 billion acquisition of Grail despite continuing antitrust scrutiny in the U.S. and Europe.
What could possibly unite a drug developer with a manufacturer of electric cars? It’s all in the narrative.
The rise of the delta variant makes testing more important than ever, even among the vaccinated. Rapid antigen tests are the right tool for the job.
Recent reports about possible carcinogens in certain sunscreens have raised safety concerns, but don't overreact. Here’s what you need to know.
The company needs to put its Covid vaccine windfall to use, but it has outlined an acquisition strategy that won't pay off anytime soon.
The World Health Organization is right to call for a halt to booster shots until more people in the developing world get their first vaccinations.
Requiring proof of inoculation for certain indoor events offers the best chance of increasing vaccine uptake and stopping the spread of the virus.
Vaccine giant Sanofi is buying out its partner in mRNA development, Translate Bio, in another validation of the promise of the technology.
U.S. vaccination rates are still too low. Employers could start offering health-insurance discounts as an incentive to get a shot.
